Page 42 - 83_01

Trichomonas vaginalis: The versatility of a tenacious parasite
105. Bastida-Corcuera FD, Okumura CY, Colocoussi A,
Johnson PJ. Trichomonas vaginalis
lipophosphoglycan mutants have reduced adherence
and cytotoxicity to human ectocervical cells. Eukaryot
Cell 2005; 4: 1951-8.
106. Singh, B.N., Hayes, G.R., Lucas, J.J., et al. Structural
details and composition of Trichomonas vaginalis
lipophosphoglycan in relevance to the epithelial
immune function. Glycoconj J 2009; 26: 3-17.
107. Okumura CY, Baum LG, Johnson PJ. Galectin-1 on
cervical epithelial cells is a receptor for the sexually
transmitted human parasite Trichomonas vaginalis.
Cell Microbiol 2008; 10: 2078-90.
108. Lama A, Kucknoor A, Mundodi V, Alderete JF.
Glyceraldehyde-3-phosphate dehydrogenase is a
surface-associated, fibronectin-binding protein of
Trichomonas vaginalis. Infect Immun 2009; 77: 2703-
11.
109. Nöel JC, Fayt I, Romero Munoz MR, Simon P,
Engohan-Aloghe C. High prevalence of high-risk
human papillomavirus infection among women with
Trichomonas vaginalis infection on monolayer
cytology. Arch Gynecol Obstet 2010; 282: 503-5.
110. Pereira-Neves A, Benchimol M. Phagocytosis by
Trichomonas vaginalis: new insights. Biol Cell 2007;
99: 87-101.
111. Midlej V, Benchimol M. Trichomonas vaginalis kills
and eats--evidence for phagocytic activity as a
cytopathic effect. Parasitol 2010; 137: 65-76.
112. Rendón-Maldonado JG, Espinosa-Cantellano M,
González-Robles A, Martínez-Palomo A.
Trichomonas vaginalis: In vitro phagocytosis of
lactobacilli, vaginal epithelial cells, leukocytes, and
erythrocytes. Exp Parasitol 1998; 89: 241-50.
113. Krieger JN, Poisson MA, Rein MF. Beta-hemolytic
activity of Trichomonas vaginalis correlates with
virulence. Infect Immun 1983; 41: 1291-5.
114. Petrin D, Delgaty K, Bhatt R, Garber G. Clinical and
microbiological aspects of Trichomonas vaginalis.
Clin Microbiol Rev 1998; 11: 300-17.
115. Lubick KJ, Burgess DE. Purification and analysis of a
phospholipase A2-like lytic factor of Trichomonas
vaginalis. Infect Immun 2004; 72: 1284-90.
116. Vargas-Villarreal J, Mata-Cárdenas BD, Palacios-
Corona R, et al. Trichomonas vaginalis: identification
of soluble and membrane-associated phospholipase
A1 and A2 activities with direct and indirect
hemolytic effects. J Parasitol 2005; 91: 5-11.
117. Hirt RP. Trichomonas vaginalis virulence factors: an
integrative overview. Sex Transm Infect 2013; 89:
439-43.
118. Neale KA, Alderete JF. Analysis of the proteinases of
representative Trichomonas vaginalis isolates. Infect
Immun 1990; 58: 157-62.
119. Alvarez-Sánchez ME, Avila-González L, Becerril-
García C, Fattel-Facenda LV, Ortega-López J, Arroyo
@Real Academia Nacional de Farmacia. Spain
R. A novel cysteine proteinase (CP65) of
Trichomonas vaginalis involved in cytotoxicity.
Microb Pathogenesis 2000; 28: 193-202.
120. Mendoza-López MR, Becerril-García C, Fattel-
Facenda LV, et al. CP30, a cysteine proteinase
involved in Trichomonas vaginalis cytoadherence.
Infect Immun 2000; 68: 4907-12.
121. Sommer U, Costello CE, Hayes GR, et al.
Identification of Trichomonas vaginalis cysteine
proteases that induce apoptosis in human vaginal
epithelial cells. J Biol Chem 2005; 280: 23853-60.
122. Arroyo R, Alderete JF. Trichomonas vaginalis
surface proteinase activity is necesssary for parasite
adherence to epithelial cells. Infect Immun 1989; 57:
2991-7.
123. Provenzano D, Alderete JF. Analysis of human
immunoglobulin-degrading cysteine proteinases of
Trichomonas vaginalis. Infect Immun 1995; 63: 3388-
95.
124. Draper D, Donohoe W, Mortimer L, Heine RP.
Cysteine proteases of Trichomonas vaginalis degrade
secretory leukocyte protease inhibitor. J Infect Dis
1998; 178: 815-9.
125. Garber GE, Lemchuk-Favel LT, Bowie WR. Isolation
of a cell-detaching factor of Trichomonas vaginalis. J
Clin Microbiol 1989; 27: 1548-53.
126. Escario A, Barrio AG, Diez BS, Escario JA.
Immunohistochemical study of the vaginal
inflammatory response in experimental
trichomoniasis. Acta Trop 2010; 114: 22-30.
127. Tai JH, Ip CF. The cDNA sequence of Trichomonas
vaginalis Virus-T1 double-stranded RNA. Virology
1995; 206: 773-6.
128. Liu HW, Chu YD, Tai JH. Characterization of
Trichomonas vaginalis virus proteins in the
pathogenic protozoan T. vaginalis. Arch Virol 1998;
143: 963-70.
129. Bessarab IN, Liu HW, Ip CF, Tai JH. The complete
cDNA sequence of a type II Trichomonas vaginalis
virus. Virology 2000; 267: 350-9.
130. Benchimol M, Chang TH, Alderete JF. Visualization
of new virus-like-particles in Trichomonas vaginalis.
Tissue Cell 2002; 34: 406-15.
131. Benchimol M, Monteiro SP, Chang TH, Alderete JF.
Virus in Trichomonas - an ultrastructural study.
Parasitol Int 2002; 51: 293-8.
132. Wang A, Wang CC, Alderete JF. Trichomonas
vaginalis phenotypic variation occurs only among
trichomonads infected with the double-stranded-RNA
virus. J Exp Med 1987; 166: 142-50.
133. Khoshnan A, Alderete JF. Trichomonas vaginalis
with a double-stranded-RNA virus has up-regulated
levels of phenotypically variable immunogen mRNA.
J Virol 1994; 68: 4035-8.
134. Bessarab IN, Nakajima R, Liu HW, Tai JH.
Identification and characterization of a type III
43